March 31, 2025
Translink Corporate Finance acted as exclusive advisor Gal-Kal on the sale to Chemitec
Translink Corporate Finance Israel acted as exclusive advisor to Gal-Kal, a leading Israeli provider of accessibility and rehabilitation solutions, on the sale to Chemitec, a healthcare company specialising in the import, distribution, and marketing of medical and assistive products.
Founded in 1985, Gal-Kal is a well-established Israeli company specialising in the development, manufacturing, and marketing of assistive seating and mobility products, with particular expertise in shower and commode chairs designed for individuals with limited mobility. Gal-Kal serves hospitals, nursing homes, rehabilitation centers, and private clients with a product range known for clinical functionality, ergonomic design, and patient comfort.
Chemitec is a leading Israeli company with over 30 years of experience in the healthcare sector, focused on medical equipment, mobility aids, rehabilitation products, and advanced home-care technologies. The company partners with hospitals, nursing homes, and other healthcare institutions, delivering high-quality solutions that meet clinical needs. Chemitec is committed to innovation, reliability, and improving the quality of life for individuals across various stages of care.
Comments from Gal-Kal
Hagai Mann, CEO of Gal-Kal, said, “The sale process was managed by Head-On / Translink Israel with the utmost professionalism, precision, and efficiency. Their guidance was hands-on, transparent, and demonstrated a deep understanding of the industry and its challenges. I am proud to say the entire process exceeded expectations – both in outcome and execution.”
Comments from Chemitec
Maya Levin-Ganor, CEO of Chemitec, said, “The acquisition of Gal-Kal marks a strategic step in expanding Chemitec’s offering in the rehabilitation and accessibility segments. Gal-Kal’s expertise and complementary product range allow us to deepen our market presence and enhance the value we provide to institutional and private clients.”
Comments from Translink Corporate Finance
Hilit Ben-Zvi Koren, Co-CEO of Head-On/Translink Israel, added, “We are proud to have advised Gal-Kal in this strategic transaction. The acquisition represents a strong synergy between two leading players in the healthcare and rehabilitation space. We believe the combined strengths of Chemitec and Gal-Kal will bring meaningful value to the Israeli healthcare ecosystem”.
Contact our Team:
Translink Corporate Finance is a world leader in cross-border mid-market M&A advisory services, specialising in transactions ranging from €10M to €250M. Established in 1972, with over five decades of experience, we get the deal done. We are a trusted global group with over 400 experts worldwide, and a proven track record with long-standing clients and deep sector specific knowledge. At Translink Corporate Finance, we are easy to approach, and our core ethos revolves around the pursuit of sustainable value creation for our clients – whose best interests always come first.
Head-On Strategy, Business & Marketing Ltd./ Translink Israel is a strategy consulting firm, specializing in business growth and corporate value enhancement. Since the early 2000s, Head-On has been assisting business owners and decision makers from all industries to address their most complex challenges in managing a company and leading it towards business growth. Our expertise in formulating and executing growth strategies, managing business development processes, creating strategic partnerships, and leading mergers and acquisitions processes, has helped hundreds of companies grow and leverage their business potential in the local and international markets.
Translink International AG
